July 13, 2026
HTA Regulation SMEs Demand Smarter Market Access Planning
Among SMEs, the HTA Regulation alters how evidence reaches decision makers and shapes…
July 6, 2026
G7 Pharma Strategy and Long-Term Value Assessment
Recent commentary on G7 Pharma Strategy highlights how leading economies can either sustain…
June 29, 2026
HTA Regulatory Interface Shapes Future Market Access
The HTA Regulatory Interface is emerging as a central factor in how European…
June 22, 2026
Pharma Market Access Challenges Shape European Competitiveness
Nathalie Moll, Director General of EFPIA, sets out why pharma market access now…
June 15, 2026
Portugal Access Delays Influence Reimbursement Strategies
Portugal access delays remain a defining challenge for health systems seeking to balance…
June 8, 2026
Incretin Economics: Strategic Lessons from New Obesity Therapies
The accelerating development of incretin-based therapies demands fresh thinking on incretin economics. Recent…